Health Subcommittee

H.R. 3164, Ensuring Community Access to Pharmacist Services Act (Reps. Smith (NE) and Schneider)

Briefing Memorandum

H.R. 1254, Rural Obstetrics Readiness Act (Rep. Kelly (IL))

H.R. 7905, Diabetes Foot Health Access and Modernization Act of 2026 (Reps. Joyce (PA) and DeGette)

The Honorable Lizzie Fletcher

The Honorable Frank Pallone

HHRG-119-IF14-20260915-MbrRoster.pdf

Statements for the Record

HHRG-119-IF14-Wstate-PudloPharmDMBAMSA-20260915.pdf

HHRG-119-IF14-Bio-PudloPharmDMBAMSA-20260915.pdf

HHRG-119-IF14-TTF-PudloPharmDMBAMSA-20260915.pdf

HHRG-119-IF14-Wstate-AndrewsMSMDMACPR-20260915.pdf

HHRG-119-IF14-TTF-AndrewsMSMDMACPR-20260915.pdf

HHRG-119-IF14-Wstate-AndrewsMSMDMACPR-20260915-SD004.pdf

Jul 152026

Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.Hearing2123 Rayburn House Office Building2:15 p.m.

Dr. Cynthia VerstPresident, Design and Delivery Innovation, R&D Solutions, IQVIAWitness Biography Witness Truth in Testimony Witness Statement — HHRG-119-IF14-Wstate-VerstC-20260715.pdf Witness Statement — HHRG-119-IF14-Wstate-VerstC-20260715-U1.pdf

Ms. Susan WincklerCEO, Reagan-Udall Foundation for the FDAWitness Biography Witness Truth in Testimony Witness Statement Witness Support Document — HHRG-119-IF14-Wstate-WincklerS-20260715-SD002.pdf Witness Support Document — HHRG-119-IF14-Wstate-WincklerS-20260715-SD003.pdf

Dr. Aaron KowalskiCEO, Breakthrough T1DWitness Biography Witness Truth in Testimony Witness Statement Witness Support Document

Dr. Thomas HwangAssistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical SchoolWitness Biography Witness Support Document Witness Truth in Testimony Witness Statement

Mr. Thomas BollykyBloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, CouncilWitness Biography Witness Statement Witness Truth in Testimony

HHRG-119-IF14-Transcript-20260715.pdf

Statement by the Honorable Brett Guthrie

Statement by the Honorable H. Morgan Griffith

Member Attendance

Statement by the Honorable Diana DeGette

Statement by the Honorable Frank Pallone, Jr.

H.R. 5880Fight Illicit Pill Presses Act

Three Pieces of LegislationMarkup2123 Rayburn House Office Building2:00 p.m.

H.R. 7184PRESS Act

H.R. 8005Stop Pills That Kill Act

CRPT-119-IF14-VoteSummary-20260715.pdf

H.R. 7184, PRESS Act (Rep. McDowell)

H.R. 8005, Stop Pills That Kill Act (Rep. Evans)

H.R. 5880, Fight Illicit Pill Presses Act (Reps. Hageman and Stansbury)

h8005-scr-ains_01_xml, an amendment in the nature of a substitute to H.R. 8005, offered by the Majority.

Markup Notice

Member Attendance

Statement by the Honorable Frank Pallone, Jr.

Statement by the Honorable Diana DeGette

Statement by the Honorable Brett Guthrie

Statement by the Honorable H. Morgan Griffith

Jun 252026

Markup of Fifteen BillsMarkup2123 Rayburn House Office Building5:00 p.m.Rescheduled

H.R. 3514Improving Seniors’ Timely Access to Care Act of 2025

H.R. 1266Combating Illicit Xylazine Act

H.R. 7970STOP Nitazenes Act

H.R. 5243To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.

H.R. 8201To amend Public Health Service Act to require community health centers to provide behavioral and mental health and substance use disorder services, and for other purposes.

H.R. 1561ALERT Communities Act

H.R. 7994HERO Act

H.R. 2004Tyler’s Law

H.R. 9392Medicare Advantage Cost Transparency Act

H.R. 9395Transparency in Medicare Advantage Steering Act

H.R. 9389Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026

H.R. 9397Premium Transparency Act

H.R. 9396Prior Authorization Accountability Act

H.R. 9390Prices on the Wall Act of 2026

H.R. 9393Lower Costs, More Transparency Act of 2026

H.R. 1266, Combatting Illicit Xylazine Act (Reps. Panetta and Pfluger)

Vote Summary

H.R. 2004, Tyler’s Law (Reps. Lieu and Latta)

H.R. 7970, STOP Nitazenes Act (Rep. Latta)

H.R. 1561, ALERT Communities Act (Reps. Crockett and Gooden)

H.R. 7994, HERO Act (Rep. Ruiz)

H.R. 9389, Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026 (Rep. Harshbarger)

H.R. 8201, Expanding Community Access to Health Services Act (Rep. Lee (NV))

H.R. 9393, Lower Costs, More Transparency Act of 2026 (Reps. Guthrie and Pallone)

H.R. 9397, Premium Transparency Act (Reps. Pfluger and Moran)

H.R. 9396, Prior Authorization Accountability Act (Rep. Goldman (TX))

H.R. 9390, Prices on the Wall Act of 2026 (Rep. Miller-Meeks)

H.R. 3514, Improving Seniors’ Timely Access to Care Act of 2025 (Reps. Kelly (PA) and DelBene)

H.R. 9392, Medicare Advantage Cost Transparency Act (Reps. DeGette and Joyce (PA))

H.R. 5243, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. (Rep. McClellan)

H.R. 9395, Transparency in Medicare Advantage Steering Act (Rep. Ocasio-Cortez)

H5243-EC-SC-AINS_01.XML (filed by Rep. Pallone) to H.R. 5243, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.

AMD to HR 9393 - H9393-AMD_01.XML (Rep. James)

AMD to HR 9393 - LANDSM_099.XML (Rep. Landsman)

AMD to HR 9393 - DEGETT_040.XML (Rep. DeGette)

AMD to HR 1266 - DEGETT_039.XML (Rep. DeGette)

CARTGA_135.XML (filed by Rep. Carter (GA)) to H.R. 9393, Lower Costs, More Transparency Act of 2026.

Memorandum

Notice

Statement by the Honorable Diana DeGette

Statement by the Honorable Frank Pallone, Jr.

Statement by the Honorable H. Morgan Griffith

Statement by the Honorable Brett Guthrie

Subcommittee Markup Transcript

Jun 102026

"Lowering Health Care Costs for All Americans: Examining Policies to Increase Health Care Transparency."Hearing2123 Rayburn House Office Building2:15 p.m.

H.R. 5582Patients Deserve Price Tags Act

H.R. 9117CHECK Act of 2026

Shawn GremmingerPresident and Chief Executive Officer · National Alliance of Healthcare Purchaser CoalitionsWitness Statement Witness Biography Witness Truth in Testimony

Benedic IppolitoSenior Fellow · American Enterprise InstituteWitness Statement Witness Truth in Testimony Witness Biography

Sophia TripoliSenior Director of Health Policy · Families USAWitness Statement Witness Support Document Witness Truth in Testimony

Carol SkenesChief of Staff · Turquoise HealthWitness Statement Witness Truth in Testimony Witness Biography

Christopher WhaleyAssociate Director of the Center for Advancing Health Policy through Research and Associate Professor of Health Services, Policy and Practice · Brown University School of Public HealthWitness Statement Witness Truth in Testimony Witness Biography

HHRG-119-IF14-Transcript-20260610.pdf

H.R. ____, [Lower Costs, More Transparency Act of 2026]

H.R. ____, [To amend title XXVII of the Public Health Service Act to require hospitals to post prices on the walls.]

H.R. ____, [To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to require the displaying of claim denial rates.]

H.R. 5582, Patients Deserve Price Tags Act (Reps. James and Goodlander)

H.R. 9117, Clear Healthcare Expense Cost Knowledge Act of 2026 (Rep. Langworthy)

H.R. ____, [To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data.]

H.R. ____, [To amend title XI of the Social Security Act to require mandatory reporting with respect to certain health-related ownership information.]

H.R. ____, [To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to ensure health insurer accountability through publishing of overhead costs and claim paym

H.R. ____, [To amend title XVIII of the Social Security Act to limit the compensation that may be paid to agents and brokers by Medicare Advantage organizations.]

Statements for the Record

May 202026

Examining the Medicare Physician Fee Schedule, MACRA, and Opportunities for Payment ReformsHearing2123 Rayburn House Office Building6:00 p.m.Rescheduled

Dr. William FoxChair-Emeritus · Board of RegentsWitness Statement — HHRG-119-IF14-Wstate-FoxW-20260520.pdf Witness Statement — HHRG-119-IF14-Wstate-FoxW-20260520.pdf Witness Biography Witness Truth in Testimony

Dr. Steven FurrFamily Medicine PhysicianWitness Statement Witness Biography Witness Truth in Testimony

Dr. Dana SmethermanChief Executive Officer · American College of RadiologyWitness Statement — HHRG-119-IF14-Wstate-SmethermanD-20260520.pdf Witness Statement — HHRG-119-IF14-Wstate-SmethermanD-20260520-SD001.pdf Witness Biography Witness Truth in Testimony

Dr. Rick SnyderPresident · HeartPlace PLLCWitness Statement Witness Truth in Testimony Witness Biography

Dr. Farzad MostashariChief Executive Officer and Founder · Aledade, Inc.Witness Statement Witness Biography Witness Truth in Testimony Witness Support Document

Dr. William FoxChair-Emeritus · ACP Board of Regents

H.R. 5160Stem Cell Therapeutic and Research Reauthorization Act of 2025

May 132026

Markup of Ten Pieces of LegislationMarkup2123 Rayburn House Office Building6:00 p.m.

H.R. 2715Destruction of Hazardous Imports Act

H.R. 2821FDA Modernization Act 3.0

H.R. 3747Accelerating Access to Dementia and Alzheimer’s Provider Training Act

H.R. 4541To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.

H.R. 8205Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

H.R. 1703Choices for Increased Mobility Act of 2026

H.R. 8209To amend the Public Health Service Act to reauthorize the school-based health centers grant program.

H.R. 5347Health Care Efficiency Through Flexibility Act

H.R. 4348To reauthorize the Kay Hagan Tick Act, and for other purposes.

Markup Notice

Markup Memorandum

H.R. 1703, Choices for Increased Mobility Act of 2025

H.R. 2715, Destruction of Hazardous Imports Act

H.R. 2821, FDA Modernization Act 3.0

H.R. 3747, Accelerating Access to Dementia and Alzheimer’s Provider Training (AADAPT) Act

H.R. 4348, To reauthorize the Kay Hagan Tick Act, and for other purposes.

H.R. 4541, EARLY Act Reauthorization of 2025

H.R. 5160, Stem Cell Therapeutic and Research Reauthorization Act of 2025

H.R. 5347, Health Care Efficiency Through Flexibility Act

H.R. 8205, Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

H.R. 8209, School-Based Health Centers Reauthorization Act of 2026

H3747-SCR-AINS_01_xml (filed by Rep. Balderson) to H.R. 3747, Accelerating Access to Dementia and Alzheimer’s Provider Training (AADAPT) Act.

H2715-SCR-AINS_01_xml (filed by Rep. Carter of Louisiana) to H.R. 2715, Destruction of Hazardous Imports Act.

H5347-EC-SC-AINS_02_xml (filed by the Majority) to H.R. 5347, Health Care Efficiency Through Flexibility Act.

H1703-SC-AINS_01_xml (filed by the Majority) to H.R. 1703, Choices for Increased Mobility Act of 2025.

Vote Summary - 05.13.26

The Honorable Frank Pallone Jr.

The Honorable Raul Ruiz

Subcommittee Markup Transcript

Apr 292026

Healthier America: Legislative Proposals on the Regulation and Oversight of FoodHearing2123 Rayburn House Office Building6:00 p.m.

H.R. 3722Do or Dye Act

H.R. 8385Food Labeling Modernization Act of 2026

H.R. 4306Food Chemical Reassessment Act of 2025

H.R. 4725TRUTH in Labeling Act

H.R. 8432To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes.

H.R. 4987Food Date Labeling Act of 2025

H.R. 1178Alpha-gal Allergen Inclusion Act

H.R. 8370Dietary Supplement Listing Act of 2026

H.R. 933Defending Domestic Orange Juice Production Act of 2025

H.R. 8431Third-Party Certification and Inspection Modernization Act of 2026

H.R. 2472INFANTS Act of 2025

H.R. 8430Federal and State Food Safety Information Sharing Act of 2026

H.R. 2615Stephen Hacala Poppy Seed Safety Act

H.R. 8412To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to revise certain regulations related to infant and toddler beverages, and for other purposes.

H.R. 7291GRAS Oversight and Transparency Act

H.R. 5832REAL Meats Act

H.R. 5882No Tricks on Treats Act of 2025

H.R. 1394CURD Act

H.R. 7366Dietary Supplement Regulatory Uniformity Act

H.R. 4958GRAS Act

H.R. 2162Honey Integrity Act

H.R. 8429Baby Food Safety Act of 2026

H.R. 5027Ban Harmful Food Dyes Act

H.R. 2511Sarah Katz Caffeine Safety Act

H.R. 3324Safer Shrimp Imports Act

H.R. 7867Infant Formula Safety Modernization Act of 2026

H.R. 8414DAIRY PRIDE Act

Mr. Steven MandernachExecutive Director, Association of Food and Drug OfficialsWitness Statement Witness Support Document — HHRG-119-IF14-Wstate-MandernachS-20260429-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-MandernachS-20260429-SD002.pdf Witness Truth in Testimony

Mr. Joseph ColalilloPresident · ShopRite of Hunterdon County, Inc.Witness Statement Witness Truth in Testimony Witness Biography

Mr. Chad Hamilton, JD, MBABoard Member, Cheese Board, International Dairy Foods AssociationWitness Statement Witness Support Document — HHRG-119-IF14-Wstate-HamiltonJDMBAC-20260429-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-HamiltonJDMBAC-20260429-SD002.pdf Witness Truth in Testimony

Mr. Scott Faber, JDExecutive Director of Government Affairs, Environmental Working GroupWitness Truth in Testimony Witness Support Document Witness Statement

Mr. Scott Faber, JDSenior Vice President, Government Affairs, Environmental Working Group

H.R. 4958, Grocery Reform and Safety (GRAS) Act

H.R. 7291, GRAS Oversight and Transparency Act

H.R. ____, [FDA Review and Evaluation for Safe, Healthy and Affordable Foods Act of 2026]

H.R. 4306, Food Chemical Reassessment Act of 2025

H.R. 8385, Food Labeling Modernization Act of 2026

H.R. 8429, Baby Food Safety Act of 2026

H.R. 7867, Infant Formula Safety Modernization Act of 2026

H.R. 4725, Transparency, Readability, Understandability, Truth, and Helpfulness (TRUTH) in Labeling Act

H.R. 2472, Improving Newborns’ Food and Nutrition Testing Safety (INFANTS) Act of 2025

H.R. 2511, Sarah Katz Caffeine Safety Act

H.R. 5882, No Tricks on Treat Act of 2025

H.R. 8370, Dietary Supplement Listing Act of 2026

H.R. 8430, Federal and State Food Safety Information Sharing Act

H.R. 3722, Do or Dye Act

H.R. 5027, Ban Harmful Food Dyes Act

H.R. 1394, Codifying Useful Regulatory Definitions (CURD) Act

H.R. 1178, Alpha-gal Allergen Inclusion Act

H.R. 2162, Honey Integrity Act

H.R. 4987, Food Date Labeling Act of 2025

H.R. 5832, Requiring Ethical and Accurate Labeling of Lab-grown (REAL) Meats Act

H.R. 7366, Dietary Supplement Regulatory Uniformity Act

H.R. 2615, Stephen Hacala Poppy Seed Safety Act

H.R. 3324, Safer Shrimp Imports Act

H.R. 933, Defending Domestic Orange Juice Production Act of 2025

H.R. 8431, Third-Party Certification and Inspection Modernization Act of 2026

H.R. 8412, No False Formula Act

H.R. 8414, Defending Against Imitations and Replacements of Yogurt, milk, and cheese to Promote Regular Intake of Dairy Everyday (DAIRY PRIDE) Act

Apr 212026

The Fiscal Year 2027 Department of Health and Human Services BudgetHearing2123 Rayburn House Office Building2:00 p.m.

The Honorable Robert F. Kennedy, Jr.Secretary · U.S. Department of Health and Human Services

The Honorable Diana Harshbarger

HHRG-119-IF14-Transcript-20260421.pdf

HHRG-119-IF14-Bio-KennedyJrR-20260421.pdf

HHRG-119-IF14-Wstate-KennedyJrR-20260421.pdf

HHRG-119-IF14-TTF-KennedyJrR-20260421.pdf

Apr 152026

Healthier America: Legislative Proposals to Improve Public HealthMeeting2123 Rayburn House Office Building2:15 p.m.

Mr. Jamie Ulmer, MAPresident and CEO, Healthcare NetworkWitness Biography Witness Support Document Witness Truth in Testimony Witness Statement

Ms. Holly Ahern, MS, MT(ASCP)Associate Professor of Microbiology, State University of New York Adirondack

Mr. René Quashie, JDVice President, Digital Health, Consumer Technology AssociationWitness Support Document Witness Truth in Testimony Witness Biography Witness Statement

Dr. Rachel F. Brem, MD, FACR, FSBICo-Founder, Chief Medical Officer, Brem Foundation to Defeat Breast Cancer and Professor and Vice-Chair Emeritus, The George Washington University

Brian Wallach & Sandra AbrevayaCo-Founders, I AM ALS

Ms. Amy L. Ronneberg, MBAChief Executive Officer, National Marrow Donor ProgramWitness Support Document Witness Truth in Testimony Witness Biography Witness Statement

H.R. 8209, School-Based Health Centers Reauthorization Act of 2026

H.R. 5160, Stem Cell Therapeutic and Research Reauthorization Act of 2025

H.R. 8205, Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

H.R. 4348, To reauthorize the Kay Hagan Tick Act, and for other purposes.

H.R. 4541, EARLY Act Reauthorization of 2025

H.R. 3747, Accelerating Access to Dementia and Alzheimer’s Provider Training Act

H.R. 6121, Promoting Physical Activity for Americans Act

H.R. ____, [Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026]

H.R. 8201, Expanding Community Access to Health Services Act

H.R. ____, [Digital Health Screeners Act of 2026]

HMTG-119-IF14-Wstate-AhernMSMTASCPH-20260415-SD003.pdf

HMTG-119-IF14-Wstate-AhernMSMTASCPH-20260415-SD002.pdf

HMTG-119-IF14-Wstate-BremMDFACRFSBIR-20260415-SD001.pdf

HMTG-119-IF14-TTF-BremMDFACRFSBIR-20260415.pdf

HMTG-119-IF14-Bio-BremMDFACRFSBIR-20260415.pdf

HMTG-119-IF14-Wstate-BremMDFACRFSBIR-20260415.pdf

HMTG-119-IF14-Wstate-AhernMSMTASCPH-20260415-SD001.pdf

HMTG-119-IF14-TTF-AhernMSMTASCPH-20260415.pdf

HMTG-119-IF14-Bio-AhernMSMTASCPH-20260415.pdf

HMTG-119-IF14-Wstate-SandraAbrevayaB-20260415.pdf

HMTG-119-IF14-TTF-SandraAbrevayaB-20260415.pdf

Mar 262026

Policies to Protect Our Communities From Illicit Drug ThreatsHearing2123 Rayburn House Office Building6:00 p.m.

H.R. 1227Alternatives to PAIN Act

H.R. 1266Combating Illicit Xylazine Act

H.R. 5880Fight Illicit Pill Presses Act

H.R. 7994HERO Act

H.R. 1561ALERT Communities Act

H.R. 8005Stop Pills That Kill Act

H.R. 7184PRESS Act

H.R. 2004Tyler’s Law

H.R. 5630To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.

H.R. 7407Prohibiting Tianeptine and Other Dangerous Products Act of 2026

H.R. 7970STOP Nitazenes Act

H.R. 2715Destruction of Hazardous Imports Act

H.R. 8000END 7-OH Act

H.R. 5629To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.

Dr. Yngvild Olsen, MD, MPHFormer Director of the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, and National Advisor, Manatt HWitness Support Document — HHRG-119-IF14-Wstate-OlsenMDMPHY-20260326-SD001.pdf Witness Truth in Testimony Witness Statement Witness Support Document — HHRG-119-IF14-Wstate-OlsenMDMPHY-20260326-SD002.pdf

Dr. K. Fred Gingrich II, DVMExecutive Director, American Association of Bovine Practitioners

Dr. Nabarun Dasgupta, PhD, MPHSenior Scientist and Gillings Innovation Fellow, University of North Carolina at Chapel HillWitness Statement Witness Biography Witness Support Document Witness Truth in Testimony

Mr. Scott OultonPresident, INTR3PID Solutions LLCWitness Statement Witness Support Document — HHRG-119-IF14-Wstate-OultonS-20260326-SD001.pdf Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-OultonS-20260326-SD002.pdf

Mr. Dennis LemmaSheriff, Seminole County, Florida, and Former President of the Major County Sheriffs of AmericaWitness Statement Witness Support Document — HHRG-119-IF14-Wstate-LemmaD-20260326-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-LemmaD-20260326-SD002.pdf Witness Biography Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-LemmaD-20260326-SD003.pdf

H.R. 1266, Combatting Illicit Xylazine Act

H.R. 5630, To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.

H.R. 5629, To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relatin

H.R. 2004, Tyler’s Law

H.R. 7970, STOP Nitazenes Act

H.R. 7184, PRESS Act

H.R. 5880, Fight Illicit Pill Presses Act

H.R. 1227, Alternatives to PAIN Act

H.R. 2715, Destruction of Hazardous Imports Act

H.R. 1561, ALERT Communities Act

H.R. 7407, Prohibiting Tianeptine and Other Dangerous Products Act of 2026

H.R. 8000, END 7-OH Act

H.R. 8005, Stop Pills That Kill Act

HHRG-119-IF14-Wstate-GingrichIIDVMK-20260326.pdf

HHRG-119-IF14-TTF-GingrichIIDVMK-20260326.pdf

Mar 182026

Lowering Health Care Costs for All Americans: An Examination of the U.S. Provider LandscapeHearing2123 Rayburn House Office Building2:15 p.m.

Dr. David H. Aizuss, MDChair, Board of Trustees · American Medical Association

Ms. Barbara MerrillCEO · American Network of Community Options and ResourcesWitness Biography Witness Support Document — HHRG-119-IF14-Wstate-MerrillB-20260318-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-MerrillB-20260318-SD002.pdf Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-MerrillB-20260318.pdf Witness Statement

Dr. Anthony DiGiorgio, DO, MHANeurosurgeon · University of California San Francisco HealthWitness Statement Witness Biography Witness Support Document Witness Truth in Testimony

Mr. R. Shawn MartinExecutive Vice President and CEO · American Academy of Family PhysiciansWitness Statement Witness Support Document Witness Truth in Testimony

Mr. Richard PollackPresident and CEO · American Hospital AssociationWitness Statement Witness Biography Witness Support Document Witness Truth in Testimony

Ms. Elizabeth MitchellPresident and CEO · Purchaser Business Group on HealthWitness Statement Witness Biography Witness Truth in Testimony

HHRG-119-IF14-Wstate-AizussMDD-20260318.pdf

HHRG-119-IF14-Bio-AizussMDD-20260318.pdf

HHRG-119-IF14-Wstate-AizussMDD-20260318-SD001.pdf

HHRG-119-IF14-TTF-AizussMDD-20260318.pdf

Feb 112026

Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply ChainHearing2123 Rayburn House Office Building3:15 p.m.

John MurphyPresident and CEO · Association for Accessible MedicinesWitness Statement Witness Biography Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-MurphyJ-20260211-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-MurphyJ-20260211-SD002.pdf

Rachel E. SachsProfessor of Law · Washington University in St. LouisWitness Biography Witness Statement Witness Support Document — HHRG-119-IF14-Wstate-SachsR-20260211-SD001.pdf Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-SachsR-20260211-SD002.pdf

Lori Reilly, Esq.Chief Operating Officer · PhRMAWitness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-ReillyEsqL-20260211-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-ReillyEsqL-20260211-SD002.pdf Witness Biography Witness Statement

John CrowleyPresident and CEO · Biotechnology Innovation OrganizationWitness Statement Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-CrowleyJ-20260211-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-CrowleyJ-20260211-SD002.pdf Witness Biography

David MarinPresident and CEO · Pharmaceutical Care Management AssociationWitness Statement Witness Biography Witness Support Document — HHRG-119-IF14-Wstate-MarinD-20260211-SD001.pdf Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-MarinD-20260211-SD002.pdf

Angie BoliverPresident and CEO · Healthcare Supply Chain AssociationWitness Statement Witness Biography Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-BoliverA-20260211-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-BoliverA-20260211-SD002.pdf

Chester “Chip” Davis, Jr.President and CEO · Healthcare Distribution Alliance

James GelfandPresident and CEO · The ERISA Industry CommitteeWitness Statement Witness Biography Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-GelfandJ-20260211-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-GelfandJ-20260211-SD002.pdf

B. Douglas HoeyChief Executive Officer · National Community Pharmacists AssociationWitness Biography Witness Statement Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-HoeyB-20260211-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-HoeyB-20260211-SD002.pdf

HHRG-119-IF14-Bio-DavisJrC-20260211.pdf

HHRG-119-IF14-Wstate-DavisJrC-20260211.pdf

HHRG-119-IF14-TTF-DavisJrC-20260211.pdf

HHRG-119-IF14-Wstate-DavisJrC-20260211-SD001.pdf

HHRG-119-IF14-Wstate-DavisJrC-20260211-SD002.pdf

Jan 222026

Lowering Health Care Costs for All Americans: An Examination of Health Insurance AffordabilityMeeting2123 Rayburn House Office Building2:45 p.m.

Mr. Paul MarkovichPresident and CEO · AscendiunWitness Support Document — HMTG-119-IF14-Wstate-MarkovichP-20260122.pdf Witness Statement Witness Biography Witness Truth in Testimony Witness Support Document — HMTG-119-IF14-Wstate-MarkovichP-20260122-SD001.pdf

Ms. Gail BoudreauxPresident and CEO · Elevance HealthWitness Support Document — HMTG-119-IF14-Wstate-BoudreauxG-20260122-SD002.pdf Witness Support Document — HMTG-119-IF14-Wstate-BoudreauxG-20260122.pdf Witness Support Document — HMTG-119-IF14-Wstate-BoudreauxG-20260122-SD004.pdf Witness Support Document — HMTG-119-IF14-Wstate-BoudreauxG-20260122-SD005.pdf Witness Statement Witness Biography Witness Truth in Testimony Witness Support Document — HMTG-119-IF14-Wstate-BoudreauxG-20260122-SD001.pdf

Mr. David JoynerChairman and CEO · CVS HealthWitness Support Document — HMTG-119-IF14-Bio-JoynerD-20260122.pdf Witness Statement Witness Biography Witness Truth in Testimony Witness Support Document — HMTG-119-IF14-Wstate-JoynerD-20260122-SD001.pdf

Mr. Stephen HemsleyCEO · UnitedHealth GroupWitness Support Document — HMTG-119-IF14-Wstate-HemsleyS-20260122-SD003.pdf Witness Statement Witness Support Document — HMTG-119-IF14-Wstate-HemsleyS-20260122.pdf Witness Biography Witness Truth in Testimony Witness Support Document — HMTG-119-IF14-Wstate-HemsleyS-20260122-SD001.pdf

Mr. David CordaniPresident, CEO, and Chairman of the Board · The Cigna GroupWitness Biography Witness Support Document — HMTG-119-IF14-Wstate-CordaniD-20260122-SD001.pdf Witness Support Document — HMTG-119-IF14-Wstate-CordaniD-20260122-SD002.pdf Witness Support Document — HMTG-119-IF14-Wstate-CordaniD-20260122-SD003.pdf Witness Statement Witness Truth in Testimony

Ms. Ellen AllenExecutive Director · West Virginians for Affordable Health CareWitness Statement Witness Biography Witness Truth in Testimony Witness Support Document

H.R. 1703Choices for Increased Mobility Act of 2026

Jan 82026

Legislative Proposals to Support Patient Access to Medicare ServicesHearing2123 Rayburn House Office Building3:15 p.m.

H.R. 2902SOAR Act of 2025

H.R. 5347Health Care Efficiency Through Flexibility Act

H.R. 6361Ban AI Denials in Medicare Act

H.R. 2172Preserving Patient Access to Home Infusion Act

H.R. 5243To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.

H.R. 5269RESULTS Act

H.R. 2477Portable Ultrasound Reimbursement Equity Act of 2025

H.R. 2005DMEPOS Relief Act of 2025

H.R. 6210Senior Savings Protection Act

Ms. Susan Van MeterPresident · American Clinical Laboratory AssociationWitness Statement Witness Truth in Testimony Witness Support Document

Ms. Connie SullivanPresident and CEO · National Home Infusion AssociationWitness Truth in Testimony Witness Support Document Witness Statement

Mr. Thomas RyanPresident and CEO · American Association for HomecareWitness Support Document — HHRG-119-IF14-Wstate-RyanT-20260108.pdf Witness Support Document — HHRG-119-IF14-Wstate-RyanT-20260108-SD002.pdf Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-RyanT-20260108-SD001.pdf Witness Statement

Mr. David Lipschutz, JDAttorney and Co-Director of Law and Policy · Center for Medicare AdvocacyWitness Statement Witness Support Document — HHRG-119-IF14-Wstate-LipschutzJDD-20260108-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-LipschutzJDD-20260108-SD002.pdf

H.R. 2005, DMEPOS Relief Act of 2025

H.R. 2902, Supplemental Oxygen Access Reform (SOAR) Act of 2025

H.R. 6210, Senior Savings Protection Act

H.R. 5269, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025

H.R. 5347, Health Care Efficiency Through Flexibility Act

H.R. 2477, Portable Ultrasound Reimbursement Equity Act of 2025

H.R. 2172, Preserving Patient Access to Home Infusion Act

H.R. 1703, Choices for Increased Mobility Act of 2025

H.R. 6361, Ban AI Denials in Medicare Act

H.R. 5243, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.

H.R. 842Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Sep 182025

Examining Policies to Enhance Seniors’ Access to Breakthrough Medical TechnologiesHearing2123 Rayburn House Office Building1:45 p.m.Rescheduled

H.R. 3826Expanding Access to Diabetes Self-Management Training Act of 2025

Mr. Roger RoysePatient Advocate and Partner · Haynes and Boone, LLPWitness Statement Witness Truth in Testimony Witness Support Document

Dr. Diana ZuckermanPresident · National Center for Health ResearchWitness Truth in Testimony Witness Statement Witness Support Document

Dr. Todd BrintonCorporate Vice President, Advanced Technology, and Chief Scientific Officer · Edwards LifesciencesWitness Statement Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-BrintonT-20250918-SD001.pdf Witness Support Document — HHRG-119-IF14-Wstate-BrintonT-20250918-SD002.pdf

Mr. David LipschutzCo-Director of Law and Policy · Center for Medicare AdvocacyWitness Support Document — HHRG-119-IF14-Wstate-LipschutzD-20250918-SD002.pdf Witness Statement Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-LipschutzD-20250918-SD001.pdf

Mr. Stephen EzellVice President, Global Innovation Policy, and Director, Center for Life Sciences Innovation · Information Technology and Innovation FoundationWitness Statement Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-EzellS-20250918-U1.pdf Witness Support Document — HHRG-119-IF14-Wstate-EzellS-20250918-SD002.pdf

Hearing Member Roster

H.R. ___, [To amend title XVIII of the Social Security Act...determinations.]

H.R. 842, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

H.R. 3826, Expanding Access to Diabetes Self-Management Training Act of 2025

H.R. ___, [Ensuring Patient Access to Critical Breakthrough Products Act of 2025]

The Honorable Raul Ruiz

Sep 102025

Subcommittee Markup of Seven BillsMarkup2123 Rayburn House Office Building2:15 p.m.

H.R. 4262To reauthorize programs related to health professions education, and for other purposes.

H.R. 3419To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs.

H.R. 3302Healthy Start Reauthorization Act of 2025

H.R. 2493Improving Care in Rural America Reauthorization Act of 2025

H.R. 2846To amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries).

H.R. 3593Title VIII Nursing Workforce Reauthorization Act of 2025

H.R. 4709Newborn Screening Saves Lives Reauthorization Act of 2025

H.R. 3593, Title VIII Nursing Workforce Reauthorization Act of 2025

H.R. 4709, Newborn Screening Saves Lives Reauthorization Act of 2025

Subcommittee Markup Notice

Subcommittee Markup Memorandum

H.R. 3302, Healthy Start Reauthorization Act of 2025

H.R. 3419, To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs.

H.R.2846, To amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leav

Vote Summary

H.R. 2493, Improving Care in Rural America Reauthorization Act of 2025

01. h4262-scd-ains_01_xml (filed by Rep. Ruiz) to H.R. 4262 To reauthorize programs related to health professions education, and for other purposes.

Member Attendance

H.R. 4262, To reauthorize programs related to health professions education, and for other purposes.

Sep 32025

Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence TechnologiesHearing2123 Rayburn House Office Building2:15 p.m.

Mr. Andrew ToyChief Executive Officer · Clover HealthWitness Support Document — HHRG-119-IF14-Wstate-ToyA-20250903-SD001.pdf Witness Biography Witness Truth in Testimony Witness Statement Witness Support Document — HHRG-119-IF14-Wstate-ToyA-20250903-SD002.pdf

Dr. Michelle MelloProfessor of Law, Professor of Medicine · Stanford UniversityWitness Truth in Testimony Witness Statement Witness Support Document

Dr. Vaile WrightSenior Director, Health Care Innovation · American Psychological AssociationWitness Support Document — HHRG-119-IF14-Wstate-WrightV-20250903-SD001.pdf Witness Truth in Testimony Witness Statement Witness Support Document — HHRG-119-IF14-Wstate-WrightV-20250903.pdf

Dr. Andrew IbrahimChief Clinical Officer · Viz.aiWitness Support Document Witness Biography Witness Truth in Testimony

Mr. TJ ParkerLead Investor · General MedicineWitness Biography Witness Truth in Testimony Witness Support Document

HHRG-119-IF14-20250903-MbrRoster.pdf

H.R. 3686SAFE Sunscreen Standards Act

Jul 162025

Legislative Proposals to Maintain and Improve the Public Health Workforce, Rural Health, and Over-the-Counter MedicinesHearing2123 Rayburn House Office Building2:00 p.m.

H.R. 2493Improving Care in Rural America Reauthorization Act of 2025

H.R. 3302Healthy Start Reauthorization Act of 2025

H.R. 2821FDA Modernization Act 3.0

H.R. 4273Over-the-Counter Monograph Drug User Fee Amendments

H.R. 3419To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs.

Dr. Jacqueline Corrigan-CurayActing Director for Center for Drug Evaluation and Research (CDER) · U.S. Food and Drug AdministrationWitness Statement Witness Truth in Testimony Witness Biography

Dr. Candice ChenActing Associate Administrator for Health Workforce · U.S. Health Resources and Services AdministrationWitness Truth in Testimony Witness Biography Witness Statement

Mr. Tom MorrisAssociate Administrator for Rural Health Policy · U.S. Health Resources and Services AdministrationWitness Truth in Testimony Witness Biography Witness Statement

H.R. ____, [Newborn Screening Saves Lives Reauthorization Act of 2025]

H.R. ____, [Title VII Reauthorization]

H.R. ____, [Title VIII Reauthorization]

H.R. 2493, Improving Care in Rural America Reauthorization Act of 2025

H.R. 2821, FDA Modernization Act 3.0

H.R. 2846, To amend title II of the Public Health Service Act

H.R. 3302, Healthy Start Reauthorization Act of 2025

H.R. 3419, To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs

H.R. 3686, SAFE Sunscreen Standards Act

H.R. 4273, Over-the-Counter Monograph Drug User Fee Amendments

HHRG-119-IF14-20250716-MbrRoster.pdf

H.R. 1178Alpha-gal Allergen Inclusion Act

Jul 92025

Legislative Proposals to Maintain and Improve the Public Health Workforce, Rural Health, and Over-the-Counter MedicinesHearing2123 Rayburn House Office Building2:15 p.m.Postponed

H.R. 2821FDA Modernization Act 3.0

H.R. 3686SAFE Sunscreen Standards Act

H.R. 3302Healthy Start Reauthorization Act of 2025

H.R. 2493Improving Care in Rural America Reauthorization Act of 2025

H.R. 3419To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs.

H.R. 4273Over-the-Counter Monograph Drug User Fee Amendments

H.R. 3419, To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs

H.R. 2493, Improving Care in Rural America Reauthorization Act of 2025

H.R. 4273, Over-the-Counter Monograph Drug User Fee Amendments

H.R. 2821, FDA Modernization Act 3.0

H.R. ____, [Newborn Screening Saves Lives Reauthorization Act of 2025]

H.R. ____, [Title VIII Reauthorization]

H.R. ____, [Title VII Reauthorization]

H.R. 1178, Alpha-gal Allergen Inclusion Act

H.R. 3302, Healthy Start Reauthorization Act of 2025

H.R. 3686, SAFE Sunscreen Standards Act

H.R. 2846, To amend title II of the Public Health Service Act

H.R. ____, [Vector-Borne Diseases Reauthorization]

Jun 242025

The Fiscal Year 2026 Department of Health and Human Services BudgetHearing2123 Rayburn House Office Building2:00 p.m.

The Honorable Robert KennedySecretary · U.S. Department of Health and Human ServicesWitness Support Document Witness Statement Witness Truth in Testimony Witness Biography

HHRG-119-IF14-20250624-MbrRoster.pdf

The Honorable Earl L. “Buddy” Carter

Jun 112025

Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply ChainHearing2123 Rayburn House Office Building2:00 p.m.

Dr. Ronald Piervincenzi, PhDChief Executive Officer · United States PharmacopeiaWitness Statement Witness Biography Witness Truth in Testimony Witness Support Document

Mr. Patrick CashmanPresident · USAntibioticsWitness Truth in Testimony Witness Biography Witness Support Document Witness Statement

Mr. John Murphy, IIIPresident and Chief Executive Officer · Association for Accessible Medicines (Minority)Witness Statement Witness Biography Witness Truth in Testimony Witness Support Document

Ms. Dawn O’ConnellFormer Assistant Secretary for Preparedness and Response (Minority)Witness Support Document — HHRG-119-IF14-Wstate-OConnellD-20250611-SD002.pdf Witness Biography Witness Statement Witness Truth in Testimony Witness Support Document — HHRG-119-IF14-Wstate-OConnellD-20250611.pdf

Mr. Josh BolinAssociate Executive Director, Government Affairs and Innovation · National Association of Boards of PharmacyWitness Biography Witness Support Document Witness Truth in Testimony Witness Statement

HHRG-119-IF14-20250611-MbrRoster.pdf

The Honorable Earl L. “Buddy” Carter

Apr 12025

Examining the FDA’s Regulation of Over-the-Counter Monograph DrugsHearing2123 Rayburn House Office Building2:15 p.m.

Mr. Carl D’Ruiz, MPHSenior Science, Advocacy, and Business Development Manager for Beauty and Care, North AmericaWitness Statement Witness Truth in Testimony Witness Biography Witness Support Document

Mr. Scott FaberSenior Vice President, Government AffairsWitness Biography Witness Truth in Testimony Witness Statement

Mr. Kevin MenzelMember, Board of Directors, Consumer Healthcare Products Association;Witness Biography Witness Truth in Testimony Witness Statement Witness Support Document

Ms. Kim Wezik, MPHDirector of AdvocacyWitness Support Document Witness Statement Witness Biography Witness Truth in Testimony

Mr. Douglas TroutmanInterim Co-Chief Executive OfficerWitness Truth in Testimony Witness Biography Witness Statement

HHRG-119-IF14-20250401-MbrRoster.pdf

The Honorable Earl L. "Buddy" Carter

The Honorable Frank Pallone

Documents For the Record

HHRG-119-IF14-Transcript-20250401.pdf

Feb 262025

An Examination of How Reining in PBMs Will Drive Competition and Lower Costs for PatientsHearing2123 Rayburn House Office Building3:00 p.m.

Dr. Matthew Fiedler, PhDJoseph A. Pechman Senior Fellow · Center on Health Policy, Brookings InstitutionWitness Truth in Testimony Witness Biography Witness Support Document

Mr. Hugh Chancy, RPhPharmacist and Owner · Chancy DrugsWitness Biography Witness Truth in Testimony Witness Statement Witness Support Document

Mr. Shawn Gremminger, MPHPresident and CEO · National Alliance of Healthcare Purchaser CoalitionsWitness Statement Witness Biography Witness Truth in Testimony Witness Support Document

Mr. Anthony WrightExecutive Director · Families USAWitness Truth in Testimony Witness Biography Witness Support Document

The Honorable Earl L. "Buddy" Carter

HHRG-119-IF14-20250226-MbrRoster.pdf

The Honorable Frank Pallone

HHRG-119-IF14-Transcript-20250226.pdf